Linyi Xinghua Medical Equipment Co., Ltd. is mainly engaged in the research and development, production and sales of high-value medical equipment consumables such as medical interventional catheters. Relying on a mature scientific research team and after years of development, it has broken through and mastered a number of key technologies to prevent interventional injury anesthesia Catheters, spiral steel wire reinforced nerve block catheters and other microcatheters have core products, which are advanced scientific and technological enterprises in sub-sectors and national high-tech enterprises. The company has obtained more than 20 national patents, 5 software copyrights, and 6 invention patents that have entered the substantive examination stage.

 

Founded in 1995, the company has R&D centers in Shanghai and Shenzhen, a marketing center in Guangzhou, and offices in Germany and Japan. It is a multinational company integrating production, education and research.

 

Represented by the third-generation epidural anesthesia catheter, it has strong technological leadership and scientific research advantages in the field of interventional injury prevention and spiral steel wire reinforcement. With international high-end products, it not only fills the domestic gap but also exports to the United States, Europe, the Middle East, Southeast Asia and other countries, and cooperates with Linyi University, Shandong Medical Device Research Institute, Qingdao University of Science and Technology, South China University of Technology, Beijing University of Chemical Technology and other scientific research institutions. Flexible anti-damage epidural anesthesia catheters and spiral steel wire reinforced catheters have been used in more than 50 domestic companies, including the PLA General Hospital (301), Armed Police General Hospital, Peking University People’s Hospital, Beijing Chaoyang Hospital, Shandong University Qilu Hospital, Shandong Provincial Hospital, etc. Authoritative anesthesiologists in the hospital highly appraise and approve.

 

In the next stage, the company will be based in the field of medical interventional catheters and microcatheters, and continue to explore the application of the company's core technology in new fields and new indications of anti-interventional injury materials, so as to create the industry's three outstanding technical representatives and technological innovations. enterprise. At the same time, it strengthens close cooperation with scientific research institutes at home and abroad. The company continues to explore domestic blank areas with clinical needs. Relying on its core technology reserves and scientific research capabilities, it realizes the domestic substitution of key medical devices in order to promote the rapid development of the company while improving People's living standards and medical quality, and seek common development opportunities with the country.